Neftaly Pelvic Inflammatory Disease (PID) Management

Overview:
Pelvic Inflammatory Disease (PID) is an infection of the female upper genital tract, including the uterus, fallopian tubes, and ovaries. It is commonly caused by ascending bacterial infections, often linked to sexually transmitted infections such as Chlamydia trachomatis and Neisseria gonorrhoeae. Prompt diagnosis and effective management are crucial to prevent serious complications such as infertility, ectopic pregnancy, and chronic pelvic pain.

---

Diagnosis

• Clinical Presentation: Patients typically present with lower abdominal pain, fever, abnormal vaginal discharge, dyspareunia (painful intercourse), and sometimes irregular menstrual bleeding.
• Physical Examination: Pelvic tenderness, cervical motion tenderness, and adnexal tenderness are key findings.
• Laboratory Tests:
  • Endocervical or vaginal swabs for Chlamydia and Gonorrhea PCR testing.
  • Complete blood count (CBC) for leukocytosis.
  • C-reactive protein (CRP) or ESR may be elevated.
• Imaging: Transvaginal ultrasound may help exclude other causes of pelvic pain and detect tubo-ovarian abscess.

---

Management

1. Antibiotic Therapy

• Initiate broad-spectrum empirical antibiotics promptly to cover likely pathogens, including anaerobes, Gram-negative facultative bacteria, and streptococci.
• Common regimens:
  • Outpatient:
    • Ceftriaxone 500 mg IM single dose (for N. gonorrhoeae) PLUS
    • Doxycycline 100 mg orally twice daily for 14 days (for C. trachomatis and other bacteria) PLUS
    • Metronidazole 500 mg orally twice daily for 14 days (to cover anaerobes)
  • Inpatient: (severe cases or failure of outpatient treatment)
    • Cefoxitin 2 g IV every 6 hours PLUS doxycycline 100 mg orally or IV every 12 hours
• Adjust antibiotics based on culture results and clinical response.

2. Supportive Care

• Analgesia for pain control.
• Adequate hydration and rest.
• Patient education on adherence to treatment and avoidance of sexual intercourse until therapy is completed and symptoms resolve.

3. Follow-Up

• Re-evaluate clinically within 48-72 hours to ensure improvement.
• If no improvement or worsening, consider hospitalization, further investigations, or surgical consultation.

4. Partner Management

• Sexual partners within the last 60 days should be evaluated and treated to prevent reinfection and further spread.

5. Complications Management

• Abscess drainage may be necessary if tubo-ovarian abscess is identified.
• Referral to gynecology for persistent or complicated cases.

---

Prevention

• Routine screening for STIs, especially in sexually active women under 25 and those at higher risk.
• Promote condom use and safe sexual practices.
• Educate on symptoms of PID for early recognition.

---

Neftaly is committed to providing up-to-date clinical guidance to ensure effective management of Pelvic Inflammatory Disease, improving patient outcomes and reducing long-term reproductive health complications.